CHAPTER 215
SB 289 - FINAL VERSION
21Apr2022... 1336h
2022 SESSION
22-2984
05/11
SENATE BILL 289
SPONSORS: Sen. Sherman, Dist 24; Sen. Rosenwald, Dist 13; Sen. Bradley, Dist 3; Sen. Watters, Dist 4; Sen. Carson, Dist 14; Sen. Gray, Dist 6; Sen. D'Allesandro, Dist 20; Sen. Ward, Dist 8; Sen. Prentiss, Dist 5; Sen. Cavanaugh, Dist 16; Rep. Merchant, Sull. 4; Rep. Murphy, Graf. 12; Rep. Woods, Merr. 23; Rep. Knirk, Carr. 3; Rep. Marsh, Carr. 8
COMMITTEE: Health and Human Services
─────────────────────────────────────────────────────────────────
AMENDED ANALYSIS
This bill changes a statutory reference from glucagon injections to glucagon administration. This bill also adds a requirement to the dispenser report under the controlled drug prescription health and safety program.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
21Apr2022... 1336h 22-2984
05/11
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Two
Be it Enacted by the Senate and House of Representatives in General Court convened:
215:1 Glucagon Administration. Amend the section heading of RSA 200:40-b to read as follows:
200:40-b Glucagon [Injections] Administration.
215:2 New Subparagraph; Controlled Drug Prescription Health and Safety Program; Dispenser Report. Amend RSA 126-A:91, VI by inserting after subparagraph (o) the following new subparagraph:
(p) The format of the prescription: electronic, faxed, written, oral, or other.
I. Section 1 of this act shall take effect 60 days after its passage.
II. The remainder of this act shall take effect upon its passage.
Approved: June 17, 2022
Effective Date:
I. Section 1 effective August 16, 2022
II. Remainder effective June 17, 2022